Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Testosterone therapy increases bone density in older men with low testosterone levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

DEEPLY ROOTED® supplement seems to effectively improve hair growth and quality in women with no side effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Balding men had lower bone density, while balding women had higher hip bone density.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.